Tag: EPITOPE

Viaskin Patch

DBV Announces Positive Topline Results from Phase 3 Trial of Viaskin...

News Wire ~ 3rd Party Press Release -
Viaskin Peanut demonstrated a statistically significant treatment effect with 67.0% of subjects meeting the treatment responder criteria after 12 months.
Viaskin Patch

Will the Viaskin “Patch” Therapy for Peanut Allergy be Approved Soon?...

Dave Bloom -
Company is restructuring in anticipation of delays.
Viaskin Patch

Viaskin Peanut Completes Phase III Part A Study of Toddlers With...

News Wire ~ 3rd Party Press Release -
Part B expected to commence in 2018Q4 with Viaskin Peanut 250 µg.
SnackSafely.com

Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of service and Privacy Policy.

SnackSafely.com, PO Box 141, Hillsdale, NJ 07642

©2020 SnackSafely.com Inc. All rights reserved.